Bcl-xL Genetic Modification Enhanced the Therapeutic Efficacy of Mesenchymal Stem Cell Transplantation in the Treatment of Heart Infarction

Table 1

Echocardiography at 4 weeks after MSC transplantation.

Group	LVDd (mm)	LVDs (mm)	LVEF (%)	LVFS (%)
Sham	4.57 ± 0.03	2.34 ± 0.04	82.95 ± 0.95	48.80 ± 0.10
Medium	6.87 ± 0.03	5.06 ± 0.07	44.79 ± 0.25	26.35 ± 0.35
Vector-MSC	6.66 ± 0.04	4.81 ± 0.03	47.22 ± 0.09	27.78 ± 0.39
hBcl-xL-MSC	5.99 ± 0.01	3.89 ± 0.04	59.60 ± 0.30	35.06 ± 0.11

Differences of statistical significance versus medium group, = 6, .
Differences of statistical significance versus vector-MSC group, = 6, .